International Immunology Advance Access originally published online on December 21, 2007
International Immunology 2008 20(2):209-214; doi:10.1093/intimm/dxm135
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Differential roles for IFN-
and IL-17 in experimental autoimmune uveoretinitis
1 Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka
2 Division of Molecular and Cellular Immunology, Medical Institute of Bioregulation, Kyushu University, Fukuoka
3 Department of Biomolecular Sciences, Faculty of Medicine, Saga University, Saga
4 Center for Experimental Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan
Correspondence to: H. Yoshida; E-mail: yoshidah{at}med.saga-u.ac.jp
IL-17-producing CD4+ T cells, so called Th17 cells, constitute a newly identified inflammatogenic cell population, which is critically involved in some inflammatory diseases. To explore the role of Th17 cells in murine experimental autoimmune uveoretinitis (EAU), a model of human autoimmune uveitis where Th1 responses predominantly participate in the pathogenesis, IL-17–/– mice were immunized with interphotoreceptor retinoid-binding protein peptide 1–20 for disease induction. Funduscopic examination revealed that EAU was induced in IL-17–/– mice just like in wild-type (WT) mice at early phases of the disease. However, at later/maintenance phases, the severity was significantly reduced in IL-17–/– mice. Expression of IFN-
and MCP-1 was comparable between WT and IL-17–/– mice during the time course. In vivo blockade of IFN-
and IL-4 resulted in exacerbation of EAU at later phases with augmented IL-17 production. Taken together, our data demonstrated that IL-17/Th17 participates in the late phases of EAU and also that Th1 and Th17 responses are differentially required for EAU.
Keywords: autoimmunity, cytokines, inflammation, Th1, Th17
Transmitting editor: T. Watanabe
Received 27 April 2007, accepted 22 November 2007.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
G. Shi, M. Ramaswamy, B. P. Vistica, C. A. Cox, C. Tan, E. F. Wawrousek, R. M. Siegel, and I. Gery Unlike Th1, Th17 Cells Mediate Sustained Autoimmune Inflammation and Are Highly Resistant to Restimulation-Induced Cell Death J. Immunol., December 1, 2009; 183(11): 7547 - 7556. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sugita, Y. Usui, S. Horie, Y. Futagami, H. Aburatani, T. Okazaki, T. Honjo, M. Takeuchi, and M. Mochizuki T-Cell Suppression by Programmed Cell Death 1 Ligand 1 on Retinal Pigment Epithelium during Inflammatory Conditions Invest. Ophthalmol. Vis. Sci., June 1, 2009; 50(6): 2862 - 2870. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Rosenzweig, T. Kawaguchi, T. M. Martin, S. R. Planck, M. P. Davey, and J. T. Rosenbaum Nucleotide Oligomerization Domain-2 (NOD2)-Induced Uveitis: Dependence on IFN-{gamma} Invest. Ophthalmol. Vis. Sci., April 1, 2009; 50(4): 1739 - 1745. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Usui, M. Takeuchi, T. Hattori, Y. Okunuki, K. Nagasawa, T. Kezuka, K. Okumura, H. Yagita, H. Akiba, and H. Goto Suppression of Experimental Autoimmune Uveoretinitis by Regulatory Dendritic Cells in Mice Arch Ophthalmol, April 1, 2009; 127(4): 514 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yoshimura, K.-H. Sonoda, N. Ohguro, Y. Ohsugi, T. Ishibashi, D. J. Cua, T. Kobayashi, H. Yoshida, and A. Yoshimura Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis Rheumatology, April 1, 2009; 48(4): 347 - 354. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Doodes, Y. Cao, K. M. Hamel, Y. Wang, B. Farkas, Y. Iwakura, and A. Finnegan Development of Proteoglycan-Induced Arthritis Is Independent of IL-17 J. Immunol., July 1, 2008; 181(1): 329 - 337. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Cox, G. Shi, H. Yin, B. P. Vistica, E. F. Wawrousek, C.-C. Chan, and I. Gery Both Th1 and Th17 Are Immunopathogenic but Differ in Other Key Biological Activities J. Immunol., June 1, 2008; 180(11): 7414 - 7422. [Abstract] [Full Text] [PDF] |
||||



